Advisor Group Holdings, Inc. Xeris Biopharma Holdings, Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 42,709 shares of XERS stock, worth $425,381. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,709
Previous 43,029
0.74%
Holding current value
$425,381
Previous $200,000
0.5%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding XERS
# of Institutions
219Shares Held
89.9MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$97.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$38.2 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$37.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$36.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.35B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...